31 shares received institutional buy ratings today, and 7 shares have an upside of more than 20%
DATE:  Feb 07 2025

31 stocks received institutional buy ratings today, and 5 stocks were paid attention to by institutions for the first time.

According to the statistics of Securities Times and Databao, a total of 34 buy rating records were issued in today's institutional research reports, involving a total of 31 stocks. Aibo Medical has received the highest attention, with a total of 3 institutional buy ratings.

A total of 9 of the stocks with institutional buy ratings today have given future price targets to the relevant stocks. Comparison with the latest closing price of the announced forecast target price shows that a total of 7 shares have an upside of more than 20%, and the industrial Fortune Union has the highest upside, on February 7, Huatai Securities expects the company's target price to be 37.20 yuan, with an upside of 72.62%, and stocks with higher upside are Kweichow Moutai, CIMC, etc., with an upside of 42.55% and 30.43% respectively.

From the perspective of institutional rating changes, among today's institutional buy rating records, there are 5 rating records that institutions have paid attention to for the first time, involving 5 stocks such as Palin Biotech and Shanghai Pudong Development Bank.

In terms of market performance, stocks with institutional buy ratings rose an average of 2.11% today, outperforming the Shanghai Composite Index. There are 24 stock prices that have risen, and there are Wolong electric drives. The top gainers are Ruoyuchen, Zhongji Innolight, Jingzhida, etc., with today's gains of 7.21%, 6.71%, and 5.97% respectively. Stocks with large declines include Nine Company, Shanghai Pudong Development Bank, Bank of Hangzhou, etc., with declines of 2.77%, 0.86%, and 0.47% respectively.

In terms of performance, 7 stocks have been announced by institutions to buy stocks, and the net profit growth rate is higher than that of Babi Food, Aibo Medical, and Shanghai Pudong Development Bank, with an increase of 29.64%, 27.36%, and 23.31% respectively. A total of 14 announced the annual performance forecast, in terms of the median net profit growth, the highest net profit growth is CIMC, the company is expected to increase the annual performance net profit by 612.00% year-on-year, followed by Goertek, Zhongji Innolight, etc., the median net profit growth rate is expected to be 145.00% and 139.25% respectively.

From the perspective of industries, machinery and equipment, food and beverage and other industries are the most favored, with 4 stocks on the list of institutional buy ratings. Banking, medicine and biology and other industries are also more concerned by institutions, with 4 and 3 stocks on the list respectively. (Data Treasure).

Institutional buy rating record today

  

Code Abbreviation Name of the institution Latest ratings Last rating Forecast < BR/> target price (yuan). The latest closing < BR/> price (yuan).
600519 Kweichow Moutai Dongxing Securities Highly recommended Highly recommended 2047.00 1436.00
688050 Aibo Medical Haitong Securities Better than the market Better than the market 108.16 96.29
600132 Chongqing beer Hua Chuang Securities Strong push Strong push 67.00 55.20
601138 Fortune Federation of Industries Huatai Securities Buy-in Buy-in 37.20 21.55
000403 Palin Bio CICC Outperform the industry Not rated 25.50 21.65
300772 Yunda shares CICC Outperform the industry Outperform the industry 15.89 12.77
600000 Shanghai Pudong Development Bank Haitong Securities Better than the market Not rated 12.75 10.34
000039 CIMC Huatai Securities Buy-in Buy-in 10.50 8.05
603323 Sunon Bank Huatai Securities Buy-in Buy-in 6.38 5.31
688333 BLT Zheshang Securities Overweight Overweight   53.53
688627 Jingzhida Founder Securities Recommended Recommended   84.99
689009 Company Nine China Merchants Securities Highly recommended Highly recommended   50.88
605338 Babi Foods Great Wall Securities Buy-in Buy-in   17.90
688050 Aibo Medical Founder Securities Recommended Recommended   96.29
688050 Aibo Medical Guosheng Securities Buy-in Buy-in   96.29
601665 Qilu Bank Changjiang Securities Buy-in Buy-in   5.88
000528 Liugong Great Wall Securities Buy-in Buy-in   11.05
000625 Changan Automobile Donghai Securities Buy-in Buy-in   13.54
000625 Changan Automobile Minsheng Securities Recommended Recommended   13.54
000893 Potassium International Guosen Securities Better than the market Better than the market   21.11
001328 Dengkang Oral Cavity Tianfeng Securities Overweight Overweight   33.78
002241 Goertek shares Great Wall Securities Overweight Overweight   29.43
002572 Sophia Huafu Securities Buy-in Not rated   15.88
002601 Longbai Group Dongxing Securities Highly recommended Highly recommended   18.03
002984 Mori Kirin Shenwan Hongyuan Overweight Overweight   25.29
003010 Ruo Yuchen Shenwan Hongyuan Buy-in Not rated   30.50
300308 Zhongji Innolight Great Wall Securities Buy-in Buy-in   107.78
600079 Humanwell Pharmaceutical Great Wall Securities Overweight Not rated   21.67
300782 Zhuo Sheng Wei Great Wall Securities Overweight Overweight   84.36
301061 Ingenuity in the home Shenwan Hongyuan Buy-in Buy-in   79.11
600580 Wolong electric drive Guosen Securities Better than the market Better than the market   26.54
600872 Zhongju high-tech BOC Securities Overweight Overweight   21.20
600926 Bank of Hangzhou Zhongtai Securities Overweight Overweight   14.70
601088 China Shenhua Xiangcai Securities Overweight Overweight   38.89

Note: This article is a news report and does not constitute investment advice, the stock market is risky, and investment should be cautious.

Follow Yicai Global on

star50stocks

Ticker Name

Percentage Change

Inclusion Date